rs80358322
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002335.4(LRP5):c.4488+2T>G variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_002335.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP5 | ENST00000294304.12 | c.4488+2T>G | splice_donor_variant, intron_variant | Intron 21 of 22 | 1 | NM_002335.4 | ENSP00000294304.6 | |||
LRP5 | ENST00000529993.5 | n.*3094+2T>G | splice_donor_variant, intron_variant | Intron 21 of 22 | 1 | ENSP00000436652.1 | ||||
LRP5 | ENST00000529702.1 | c.42+2T>G | splice_donor_variant, intron_variant | Intron 1 of 3 | 3 | ENSP00000435315.1 | ||||
LRP5 | ENST00000533695.1 | n.232T>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1327514Hom.: 0 Cov.: 40 AF XY: 0.00 AC XY: 0AN XY: 653044
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change affects a donor splice site in intron 21 of the LRP5 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LRP5 are known to be pathogenic (PMID: 11719191, 16252235, 25711638). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with autosomal dominant familial exudative vitreoretinopathy (PMID: 15024691). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 6287). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
The c.4488+2T>G variant in the LRP5 gene has been reported previously in the heterozygous state in multiple related individuals with familial exudative vitreoretinopathy (FEVR) (Toomes et al., 2004). This splice site variant destroys the canonical splice donor site in intron 21. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.4488+2T>G variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.4488+2T>G as a pathogenic variant. -
Inborn genetic diseases Pathogenic:1
- -
Osteoporosis with pseudoglioma Pathogenic:1
A known canonical splicing variant, g.68439918T>G (NM_002335.4: c.4488+2T>G) in intron 21 of LRP5 was observed in a homozygous state in the proband (Toomes et al., 2004). Sanger validation and segregation analysis showed that the variant was present in homozygous state in the proband and in heterozygous state in his parents. The variant is absent in gnomAD (v4.1.0) and our in-house database of 3369 exomes. -
Familial exudative vitreoretinopathy Pathogenic:1
- -
Exudative vitreoretinopathy 4, autosomal dominant Pathogenic:1
- -
Retinal dystrophy Pathogenic:1
- -
Exudative vitreoretinopathy 4 Pathogenic:1
PM2_Supporting+PVS1_Strong+PS4_Supporting+PP4+PP1_Strong -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at